Mark E. Robson, MD - MSK Breast Oncologist & Clinical Geneticist 1275 York Avenue, Manhattan, New York 10065

Mark E. Robson, MD is a respected MSK Breast Oncologist & Clinical Geneticist located at 1275 York Avenue in New York, United States. The institution is dedicated to changing how cancer is understood and treated, with a focus on research, education, and patient care. Dr. Robson specializes in identifying and managing individuals with an increased risk for cancer, incorporating genetic information into treatment plans. He also conducts research on using genetic information to improve outcomes for those with hereditary cancers. Dr. Robson's practice is focused on managing young women with breast cancer, especially hereditary breast cancer, and he participates in developing new treatments such as PARP inhibitors. Additionally, he coordinates screening for women with mutations in BRCA1 or BRCA2. Dr. Robson works closely with nurse practitioner Odessa M. Williams to provide comprehensive care to patients at every stage of their cancer journey. Memorial Sloan Kettering offers various financial assistance programs and has relationships with many healthcare providers and plans to help patients manage their care. The institution is known for its cutting-edge research and development of new cancer treatments, with hundreds of clinical trials ongoing at any given time. Patients may be able to participate in clinical trials even if they are new to MSK. Dr. Robson's publications can be found on PubMed, an online index of research papers. MSK prioritizes transparency and requires doctors to disclose their relationships and financial interests with external entities. For more information on MSK's policies and procedures, patients can contact the Compliance Office.